Specify a stock or a cryptocurrency in the search bar to get a summary
Medistim ASA
MD1Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway. Address: Økernveien 94, Oslo, Norway, 0579
Analytics
WallStreet Target Price
2 036.19 NOKP/E ratio
32.3374Dividend Yield
2.63 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures MD1
Dividend Analytics MD1
Dividend growth over 5 years
125 %Continuous growth
9 yearsPayout Ratio 5 years average
105 %Dividend History MD1
Stock Valuation MD1
Financials MD1
Results | 2019 | Dynamics |